Impact of coronavirus disease 2019 on medical practice in endocrine and metabolic diseases in Japan: a nationwide surveillance study conducted by the Japan Endocrine Society
We investigated the impact of the Coronavirus disease 2019 (COVID-19) pandemic on the management of endocrine and metabolic disorders in Japan. We conducted a cross-sectional nationwide questionnaire survey targeting board-certified endocrinologists under the auspices of the Japan Endocrine Society....
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Japan Endocrine Society
2024-05-01
|
| Series: | Endocrine Journal |
| Subjects: | |
| Online Access: | https://www.jstage.jst.go.jp/article/endocrj/71/5/71_EJ23-0671/_html/-char/en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832591704756060160 |
|---|---|
| author | Katsunori Manaka Sayaka Kato Ryuichi Sakamoto Hajime Yamakage Tsugumi Uema Shiori Kawai Megumi Shibata Izumi Hiratsuka Sawako Nakachi Takeshi Onoue Takefumi Tsuchiya Michiaki Fukui Koshi Hashimoto Atsushi Suzuki Noriko Makita Yoshihiro Ogawa Hiroshi Arima Noriko Satoh-Asahara Hiroaki Masuzaki |
| author_facet | Katsunori Manaka Sayaka Kato Ryuichi Sakamoto Hajime Yamakage Tsugumi Uema Shiori Kawai Megumi Shibata Izumi Hiratsuka Sawako Nakachi Takeshi Onoue Takefumi Tsuchiya Michiaki Fukui Koshi Hashimoto Atsushi Suzuki Noriko Makita Yoshihiro Ogawa Hiroshi Arima Noriko Satoh-Asahara Hiroaki Masuzaki |
| author_sort | Katsunori Manaka |
| collection | DOAJ |
| description | We investigated the impact of the Coronavirus disease 2019 (COVID-19) pandemic on the management of endocrine and metabolic disorders in Japan. We conducted a cross-sectional nationwide questionnaire survey targeting board-certified endocrinologists under the auspices of the Japan Endocrine Society. The questionnaire consisted of multiple-choice questions and open-ended responses. Out of approximately 2,700 specialists, 528 (19.5%) opted to participate, suggesting a high level of interest in COVID-19 management among endocrinologists. The study found that almost half of participants had encountered cases of endocrine and metabolic disorders following COVID-19 infection or vaccination. Conditions related to thyroid diseases, glucose metabolism disorders/diabetes, and hypothalamic-pituitary disorders were particularly prevalent. Diabetes and obesity were identified as having high rates of severe cases or fatalities due to COVID-19. The study also highlighted challenges in routine diagnosis and treatment, emphasizing the potential benefits of combining remote consultations with in-person visits to optimize the frequency of examinations and check-ups during infectious disease outbreak which disrupts access to healthcare providers. The insights obtained from this survey are expected to contribute to ensuring appropriate healthcare provision for patients with endocrine and metabolic disorders by using flexible consultation formats, particularly even in the conditions where medical access may be limited due to future outbreaks of emerging or re-emerging infectious diseases. |
| format | Article |
| id | doaj-art-6959d94fddb4474db8fee16fbffea9e8 |
| institution | Kabale University |
| issn | 1348-4540 |
| language | English |
| publishDate | 2024-05-01 |
| publisher | The Japan Endocrine Society |
| record_format | Article |
| series | Endocrine Journal |
| spelling | doaj-art-6959d94fddb4474db8fee16fbffea9e82025-01-22T06:39:10ZengThe Japan Endocrine SocietyEndocrine Journal1348-45402024-05-0171549951410.1507/endocrj.EJ23-0671endocrjImpact of coronavirus disease 2019 on medical practice in endocrine and metabolic diseases in Japan: a nationwide surveillance study conducted by the Japan Endocrine SocietyKatsunori Manaka0Sayaka Kato1Ryuichi Sakamoto2Hajime Yamakage3Tsugumi Uema4Shiori Kawai5Megumi Shibata6Izumi Hiratsuka7Sawako Nakachi8Takeshi Onoue9Takefumi Tsuchiya10Michiaki Fukui11Koshi Hashimoto12Atsushi Suzuki13Noriko Makita14Yoshihiro Ogawa15Hiroshi Arima16Noriko Satoh-Asahara17Hiroaki Masuzaki18Department of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, JapanDepartment of Endocrinology, Metabolism and Hypertension Research, Clinical Research Institute, National Hospital Organization, Kyoto Medical Center, Kyoto 612-8555, JapanDepartment of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, JapanDepartment of Endocrinology, Metabolism and Hypertension Research, Clinical Research Institute, National Hospital Organization, Kyoto Medical Center, Kyoto 612-8555, JapanSecond Department of Internal Medicine (Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology), Graduate School of Medicine, University of the Ryukyus, Okinawa 903-0213, JapanDepartment of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, JapanDepartment of Endocrinology, Diabetes and Metabolism, Fujita Health University, School of Medicine, Aichi 470-1192, JapanDepartment of Endocrinology, Diabetes and Metabolism, Fujita Health University, School of Medicine, Aichi 470-1192, JapanSecond Department of Internal Medicine (Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology), Graduate School of Medicine, University of the Ryukyus, Okinawa 903-0213, JapanDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Aichi 466-8550, JapanDepartment of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, JapanDepartment of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, JapanDepartment of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, JapanDepartment of Endocrinology, Diabetes and Metabolism, Fujita Health University, School of Medicine, Aichi 470-1192, JapanDepartment of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo 113-8655, JapanDepartment of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, JapanDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Aichi 466-8550, JapanDepartment of Endocrinology, Metabolism and Hypertension Research, Clinical Research Institute, National Hospital Organization, Kyoto Medical Center, Kyoto 612-8555, JapanSecond Department of Internal Medicine (Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology), Graduate School of Medicine, University of the Ryukyus, Okinawa 903-0213, JapanWe investigated the impact of the Coronavirus disease 2019 (COVID-19) pandemic on the management of endocrine and metabolic disorders in Japan. We conducted a cross-sectional nationwide questionnaire survey targeting board-certified endocrinologists under the auspices of the Japan Endocrine Society. The questionnaire consisted of multiple-choice questions and open-ended responses. Out of approximately 2,700 specialists, 528 (19.5%) opted to participate, suggesting a high level of interest in COVID-19 management among endocrinologists. The study found that almost half of participants had encountered cases of endocrine and metabolic disorders following COVID-19 infection or vaccination. Conditions related to thyroid diseases, glucose metabolism disorders/diabetes, and hypothalamic-pituitary disorders were particularly prevalent. Diabetes and obesity were identified as having high rates of severe cases or fatalities due to COVID-19. The study also highlighted challenges in routine diagnosis and treatment, emphasizing the potential benefits of combining remote consultations with in-person visits to optimize the frequency of examinations and check-ups during infectious disease outbreak which disrupts access to healthcare providers. The insights obtained from this survey are expected to contribute to ensuring appropriate healthcare provision for patients with endocrine and metabolic disorders by using flexible consultation formats, particularly even in the conditions where medical access may be limited due to future outbreaks of emerging or re-emerging infectious diseases.https://www.jstage.jst.go.jp/article/endocrj/71/5/71_EJ23-0671/_html/-char/encoronavirus disease 2019 (covid-19)pandemicpost covid-19 condition (long covid)endocrine and metabolic diseases |
| spellingShingle | Katsunori Manaka Sayaka Kato Ryuichi Sakamoto Hajime Yamakage Tsugumi Uema Shiori Kawai Megumi Shibata Izumi Hiratsuka Sawako Nakachi Takeshi Onoue Takefumi Tsuchiya Michiaki Fukui Koshi Hashimoto Atsushi Suzuki Noriko Makita Yoshihiro Ogawa Hiroshi Arima Noriko Satoh-Asahara Hiroaki Masuzaki Impact of coronavirus disease 2019 on medical practice in endocrine and metabolic diseases in Japan: a nationwide surveillance study conducted by the Japan Endocrine Society Endocrine Journal coronavirus disease 2019 (covid-19) pandemic post covid-19 condition (long covid) endocrine and metabolic diseases |
| title | Impact of coronavirus disease 2019 on medical practice in endocrine and metabolic diseases in Japan: a nationwide surveillance study conducted by the Japan Endocrine Society |
| title_full | Impact of coronavirus disease 2019 on medical practice in endocrine and metabolic diseases in Japan: a nationwide surveillance study conducted by the Japan Endocrine Society |
| title_fullStr | Impact of coronavirus disease 2019 on medical practice in endocrine and metabolic diseases in Japan: a nationwide surveillance study conducted by the Japan Endocrine Society |
| title_full_unstemmed | Impact of coronavirus disease 2019 on medical practice in endocrine and metabolic diseases in Japan: a nationwide surveillance study conducted by the Japan Endocrine Society |
| title_short | Impact of coronavirus disease 2019 on medical practice in endocrine and metabolic diseases in Japan: a nationwide surveillance study conducted by the Japan Endocrine Society |
| title_sort | impact of coronavirus disease 2019 on medical practice in endocrine and metabolic diseases in japan a nationwide surveillance study conducted by the japan endocrine society |
| topic | coronavirus disease 2019 (covid-19) pandemic post covid-19 condition (long covid) endocrine and metabolic diseases |
| url | https://www.jstage.jst.go.jp/article/endocrj/71/5/71_EJ23-0671/_html/-char/en |
| work_keys_str_mv | AT katsunorimanaka impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT sayakakato impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT ryuichisakamoto impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT hajimeyamakage impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT tsugumiuema impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT shiorikawai impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT megumishibata impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT izumihiratsuka impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT sawakonakachi impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT takeshionoue impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT takefumitsuchiya impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT michiakifukui impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT koshihashimoto impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT atsushisuzuki impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT norikomakita impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT yoshihiroogawa impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT hiroshiarima impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT norikosatohasahara impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety AT hiroakimasuzaki impactofcoronavirusdisease2019onmedicalpracticeinendocrineandmetabolicdiseasesinjapananationwidesurveillancestudyconductedbythejapanendocrinesociety |